Clinical Outcome and Prognostic Analysis of Young Adults Nasopharyngeal Carcinoma Patients of a Nonendemic Area in Intensity-Modulated Radiotherapy Era

References

• Wei KR , ZhengRS, ZhangSW, LiangZH, LiZM, ChenWQ. Nasopharyngeal carcinoma incidence and mortality in China, 2013. Chin. J. Cancer36(1), 90 (2017).
   PubMedGoogle Scholar
• Wu SG , LiaoXL, HeZYet al. Demographic and clinicopathological characteristics of nasopharyngeal carcinoma and survival outcomes according to age at diagnosis: a population-based analysis. Oral Oncol.73, 83–87 (2017).
   PubMed Web of Science ®Google Scholar
• Xu ZJ , ZhengRS, ZhangSW, ZouXN, ChenWQ. Nasopharyngeal carcinoma incidence and mortality in China in 2009. Chin. J. Cancer32(8), 453–460 (2013).
   PubMedGoogle Scholar
• Chen L , ZhangY, LaiSZet al. 10-year results of therapeutic ratio by intensity-modulated radiotherapy versus two-dimensional radiotherapy in patients with nasopharyngeal carcinoma. Oncologist23, 1–8 (2018).
   PubMedGoogle Scholar
• Wang W , FengM, FanZ, LiJ, LangJ. Clinical outcomes and prognostic factors of 695 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy. Biomed. Res. Int.2014, 814948 (2014).
   PubMed Web of Science ®Google Scholar
• Varan A , OzyarE, CorapciogluFet al. Pediatric and young adult nasopharyngeal carcinoma patients treated with preradiation cisplatin and docetaxel chemotherapy. Int. J. Radiat. Oncol. Biol. Phys.73(4), 1116–1120 (2009).
   PubMed Web of Science ®Google Scholar
• Buehrlen M , ZwaanCM, GranzenBet al. Multimodal treatment, including interferon β, of nasopharyngeal carcinoma in children and young adults: preliminary results from the prospective, multicenter study NPC-2003-GPOH/DCOG. Cancer118(19), 4892–4900 (2012).
   PubMedGoogle Scholar
• Zhang JQ , HuangYC, LanM, FengM, LangJY. Clinical efficacy and prognostic analysis of intensity modulated radiotherapy (IMRT) for nasopharyngeal carcinoma in young adult patients[J]. J. Cancer Control Treat.31(2), 117–122 (2018).
   Google Scholar
• Lee AW , SzeWM, AuJSet al. Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience. Int. J. Radiat. Oncol. Biol. Phys.61(4), 1107–1116 (2005).
   PubMed Web of Science ®Google Scholar
• Mott FE , FerrarottoR, NguyenT, PhanJ. Nasopharyngeal carcinoma outcome with induction chemotherapy followed by concurrent chemoradiotherapy. Oral Oncol.81, 75–80 (2018).
   PubMed Web of Science ®Google Scholar
• Shuang H , FengJ, CainengCet al. The value of radical radiotherapy in the primary tumor of newly diagnosed oligo-metastatic nasopharyngeal carcinoma patients. Clin. Transl. Oncol. doi:10.1007/s12094-018-1911-7 (2018) ( Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Huang SJ , TangYY, LiuHMet al. Impact of age on survival of locoregional nasopharyngeal carcinoma: an analysis of the Surveillance, Epidemiology, and End Results Program Database, 2004–2013. Clin. Otolaryngol.43(5), 1209–1218 (2018).
   PubMed Web of Science ®Google Scholar
• Li XH , ChangH, XuBQet al. An inflammatory biomarker-based nomogram to predict prognosis of patients with nasopharyngeal carcinoma: an analysis of a prospective study. Cancer Med.6(1), 310–319 (2017).
   PubMed Web of Science ®Google Scholar
• Fountzilas G , CiuleanuE, BobosMet al. Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapy in patients with nasopharyngeal carcinoma: a randomized Phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluation. Ann. Oncol.23(2), 427–435 (2012).
   PubMed Web of Science ®Google Scholar
• Xiao G , CaoY, QiuX, WangW, WangY. Influence of gender and age on the survival of patients with nasopharyngeal carcinoma. BMC Cancer13, 226 (2013).
   PubMed Web of Science ®Google Scholar
• Ye NY , HeSG, ZhongZQ. An efficacy analysis of 96 cases of young patients with nasopharyngeal carcinoma with radiation therapy. J. Sichuan Cancer Control11(1), 20–22 (1998).
   Google Scholar
• Casanova M , OzyarE, PatteCet al. International randomized Phase II study on the addition of docetaxel to the combination of cisplatin and 5-fluorouracil in the induction treatment for nasopharyngeal carcinoma in children and adolescents. Cancer Chemother. Pharmacol.77(2), 289–298 (2016).
   PubMed Web of Science ®Google Scholar
• Han L , LinSJ, PanJJ. Prognostic factors of 305 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy. Chin. J. Cancer29(1), 153–158 (2010).
   Google Scholar
• Orlandi E , TomatisS, PotepanPet al. Critical analysis of locoregional failures following intensity-modulated radiotherapy for nasopharyngeal carcinoma. Future Oncol.9(1), 103–114 (2013).
   PubMed Web of Science ®Google Scholar
• Jiang WP , WuJX, ChenCB, ChenLS, PanJJ. Long-term results of elderly nasopharyngeal carcinoma treated with conventional radiotherapy alone in 95 cases. Chin. J. Radiat. Oncol.12(1), 7–11 (2012).
   Google Scholar
• Wang L , SongYL, HuangSMet al. [The clinical significance of EBV DNA analysis in nasopharyngeal carcinoma screening]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi32(4), 298–301 (2018).
   PubMedGoogle Scholar
• Ngan HL , WangL, LoKW, LuiVWY. Genomic landscapes of EBV-associated nasopharyngeal carcinoma vs HPV-associated head and neck cancer. Cancers10(7), pii: E210 (2018).
   PubMed Web of Science ®Google Scholar
• He Y , GuoT, GuanH, WangJ, SunY, PengX. Concurrent chemoradiotherapy versus radiotherapy alone for locoregionally advanced nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy: a meta-analysis. Cancer Manag. Res.10, 1419–1428 (2018).
   PubMed Web of Science ®Google Scholar
• Ng WT , TungSY, LeeVet al. Concurrent-adjuvant chemoradiation therapy for stage III-IVB nasopharyngeal carcinoma-exploration for achieving optimal 10-year therapeutic ratio. Int. J. Radiat. Oncol. Biol. Phys.101(5), 1078–1086 (2018).
   PubMed Web of Science ®Google Scholar
• Huang ZL , XuT, WeiW, QingHC. Long term efficacy and prognostic analysis of 214 patients with nasopharyngeal carcinoma. Chin. J. Cancer Prevent. Treat.22(7), 537–541 (2015).
   Google Scholar
• Christiansen H , WolffHA. Primary curative radiochemotherapy in nasopharyngeal carcinomas. Cumulative total cisplatin dose of prognostic significance. Strahlenther. Onkol.189(3), 269–270 (2013).
   PubMed Web of Science ®Google Scholar
• Peng H , TangLL, ChenBBet al. Optimizing the induction chemotherapy regimen for patients with locoregionally advanced nasopharyngeal carcinoma: a big-data intelligence platform-based analysis. Oral Oncol.79, 40–46 (2018).
   PubMed Web of Science ®Google Scholar
• Liang ZG , ChenXQ, LinGXet al. Significant survival benefit of adjuvant chemotherapy after concurrent chemoradiotherapy in locally advanced high-risk nasopharyngeal carcinoma. Sci. Rep.7, 41449 (2017).
   PubMed Web of Science ®Google Scholar
• He X , XuK, GuoJ, ZhuY, LiangX, LiuL. A meta-analysis of neoadjuvant chemotherapy plus radiation in the treatment of locally advanced nasopharyngeal carcinoma. J. Cancer Res. Ther.11(Suppl. 2), C205–C208 (2015).
   PubMedGoogle Scholar
• Wee CW , KeamB, HeoDS, SungMW, WonTB, WuHG. Locoregionally advanced nasopharyngeal carcinoma treated with intensity-modulated radiotherapy plus concurrent weekly cisplatin with or without neoadjuvant chemotherapy. Radiat. Oncol. J.33(2), 98–108 (2015).
   PubMedGoogle Scholar
• Liang ZG , LinGX, YeJXet al. Cetuximab or nimotuzumab versus cisplatin concurrent with radiotherapy for local-regionally advanced nasopharyngeal carcinoma: a meta-analysis. Asian Pac. J. Cancer Prev.19(5), 1397–1404 (2018).
   PubMedGoogle Scholar
• Wang F , SunQ, JiangCet al. Additional induction chemotherapy to concurrent chemotherapy and intensity-modulated radiotherapy with or without nimotuzumab in first-line treatment for locoregionally advanced nasopharyngeal carcinoma: a propensity score matched analysis. J. Cancer9(3), 594–603 (2018).
   PubMed Web of Science ®Google Scholar
• Au KH , NganRKC, NgAWYet al. Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: a report of 3328 patients (HKNPCSG 1301 study). Oral Oncol.77, 16–21 (2018).
   PubMed Web of Science ®Google Scholar
• Qiu WZ , PengXS, XiaHQ, HuangPY, GuoX, CaoKJ. A retrospective study comparing the outcomes and toxicities of intensity-modulated radiotherapy versus two-dimensional conventional radiotherapy for the treatment of children and adolescent nasopharyngeal carcinoma. J. Cancer Res. Clin. Oncol.143(8), 1563–1572 (2017).
   PubMed Web of Science ®Google Scholar